Trials / Completed
CompletedNCT02261025
The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 410 (actual)
- Sponsor
- Shanghai Jiao Tong University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The aim of present study is to examine the effect of low-dose aspirin on the incidence of cardiovascular events and mortality in patients undergoing chronic hemodialysis.
Detailed description
This study prospectively evaluate the impacts of low dose aspirin on survival and cardio-cerebral vascular events in a large cohort of Chinese patients undergoing chronic hemodialysis. Between January 2008, consecutive patients with hemodialysis with aspirin were enrolled.We examine the association of aspirin with all-cause mortality in patients matched by propensity scores using the Kaplan-Meier method and Cox models in "intention-to-treat" analyses.The secondary endpoint was rate of cardio-cerebral events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | acetylsalicylic acid | 75-100mg,per day |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2014-09-01
- Completion
- 2014-09-01
- First posted
- 2014-10-09
- Last updated
- 2014-10-23
Source: ClinicalTrials.gov record NCT02261025. Inclusion in this directory is not an endorsement.